The world’s first longevity station is honored for turning the daily weigh in into a complete view of cardiometabolic health

BOSTON, Oct. 16, 2026 /PRNewswire/ — Withings is honored to announce that Withings BodyScan 2 has been named one of TIME’s Best Inventions of 2026. The world’s first at-home longevity station, BodyScan 2 turns a simple daily weigh in into a complete cardiometabolic check, helping people see whether their everyday habits are adding years to their healthy life or taking them away.

For Withings, this honor is a meaningful milestone. Since inventing the first smart scale in 2009, the company has been guided by a simple belief: the body is already sending signals long before anything feels wrong, and everyone deserves an easy way to hear them at home. BodyScan 2 is the latest expression of that belief, built on more than 50 patents and fifteen years of medical engineering.

“When we invented the first smart scale in 2009, we believed the bathroom scale could become a window on health. BodyScan 2 shows how far that idea can go. We are honored by TIME’s recognition, and even more excited by what it represents: the future of health starts long before the doctor’s office, at home, every morning, while there is still time to change the story,” said Eric Carreel, Chairman and Co-founder of Withings.

BodyScan 2 tracks more than 60 biomarkers and fits into a routine people already have. The Daily Scan captures weight, body composition, visceral fat, heart rate and vascular age every morning in seconds. The Longevity Scan goes further: with both arms raised on the retractable handle, users get segmental body composition across six body zones through 13 frequency bioimpedance spectroscopy, a six lead ECG with AFib detection, blood oxygen (SpO2) and Blood Pressure Insight Notifications. Results appear on the color display built into the handle and sync to the Withings App, building a continuous picture of how the body changes over time.

The recognition is shared with the engineers, designers, clinicians and researchers who brought it to life, as well as the people who step on it every morning. It also marks the third time a Withings product has been named to TIME’s Best Inventions list, following Body Scan in 2022 and BeamO in 2024, and comes on the heels of BodyScan 2 being named a CES 2026 Innovation Award Honoree.

Withings BodyScan 2 is available in the US at withings.com for $599.95 and is FSA/HSA eligible. Every purchase includes a one month free trial of Withings+, which unlocks scores such as Heart Age. The full list of TIME’s Best Inventions of 2026 is available at https://time.com/collection/best-inventions/2026/ 

ABOUT WITHINGS

Withings empowers people to live longer, healthier lives. Founded in 2008, Withings invented the first smart scale just one year later and has since pioneered connected health devices that bring clinical-grade measurement into everyday life, at home and without extra effort. For its over 15 million users worldwide, Withings turns daily routines into a continuous view of their health, helping them see how their body changes over time, catch early signals before they become urgent, and share what they learn with their doctors. Withings works with leading academic and clinical research institutions to keep every measurement grounded in science. To learn more, visit withings.com. Withings. With you. For life.

PRESS CONTACT

Alex McKechnie
alex.mckechnie@12080group.com
475.399.4056

View original content:https://www.prnewswire.com/news-releases/withings-bodyscan-2-named-one-of-times-best-inventions-of-2026-302910547.html

SOURCE Withings

SALT LAKE CITY, Oct. 16, 2026 /PRNewswire/ — In honor of Breast Cancer Awareness Month, the global charity Know Your Lemons Foundation, announced a groundbreaking update to their Webby award-winning Know Your Lemons app to help improve early detection for women. This is part of the launch of the #Lemonista movement, a new initiative designed to improve confidence in self-exam, and assess an individual’s risk to create a custom screening plan using an app for the first time.

The app update and #Lemonista movement launch marks the next chapter for the charity that has already reached 2 billion people worldwide with a life-saving breast cancer awareness campaign, including Lynsey White, age 24, who discovered a lump under her armpit just a week after seeing the Know Your Lemons’ 12 symptoms image from social media. Within a few weeks she was diagnosed with breast cancer, but she met roadblocks in getting testing. 

“I was initially told it was nothing to worry about because I was so young. But Know Your Lemons gave me the confidence to advocate for myself and get the testing I needed. This is why it’s so unbelievably important to promote Know Your Lemons and make sure that people know what to look out for, so they can get detected early,” Lynsey says.

Lynsey is among a growing number of women under 40 discovering breast changes themselves, often before they are eligible for routine screening. Currently, breast cancer is the leading cause of cancer death among women ages 20 to 49 in the United States and the leading cause of cancer death among women globally.

One of the strongest predictors of surviving breast cancer is how early it is found. Yet most women have never been taught how to confidently check their breasts, and few have completed a risk assessment to determine when and how they should be screened—something the American College of Radiology recommends by age 25.

The Know Your Lemons app addresses both gaps through a new series of games that makes learning easy, engaging, and rewarding by earning two lemons in the app: one representing Confidence in knowing their body and the other representing Intelligence in knowing their personal risk and screening plan. When the two lemons are earned, they officially become a Lemonista.

Lemonistas then show their improved breast cancer awareness status by sharing the [two lemons] symbol on social media, transforming individual action into a visible global movement—and encouraging others to take charge of their breast health, too. Among others, CBS’s Elsbeth actor Carrie Preston, Christine Handy of the Hello Beautiful movie, and breast cancer radiologist Dr. Anjali Malik have endorsed the movement by adding [two lemons] to their social media profiles. 

“So often we don’t learn about breast health until we have a breast problem,” said Corrine Ellsworth-Beaumont, founder of Know Your Lemons. “Every Lemonista who shares what they’ve learned has the power to help someone else catch something early, the way Lynsey’s story shows us that we can make all the difference.”

About Know Your Lemons Foundation

Know Your Lemons is a nonprofit global organization dedicated to breast health education, reaching people in over 100 countries through its award-winning app and educational materials. EIN: 47-1133351.

Media Contact: relations@knowyourlemons.org, Know Your Lemons Foundation, knowyourlemons.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/with-breast-cancer-on-the-rise-in-young-women-the-know-your-lemons-app-is-closing-the-gap-on-late-detection-302910761.html

SOURCE Know Your Lemons Foundation

New feature lets users log symptoms, rate their impact, and see which doses they took on the days symptoms appeared

LOS ANGELES, Oct. 15, 2026 /PRNewswire/ — Peptide Tracker, the free app for logging and managing peptide protocols, today released version 2.25.0, introducing symptom tracking and a weekly check-in designed to give users a clearer picture of how they feel alongside what they take.

With the update, users can record symptoms, note how much each one got in the way of their day, and view the doses they took on the days those symptoms showed up. A new weekly check-in on the Today screen prompts users to report anything they noticed, or confirm they felt fine, in just a few taps.

“Our users have always been meticulous about logging their doses, but the other half of the story is how they actually feel,” said Kev Miller, Co-Founder and CEO of Peptide Tracker. “Symptom tracking puts both side by side, so people walk into conversations with their providers with real notes instead of fuzzy memories.”

What’s new in v2.25.0:

Symptom logging. From Symptoms on the Today screen, users can pick a symptom from a list or describe it in their own words, tap the days they noticed it, rate how much it got in the way, and add an optional note.Doses in context. Tapping any logged symptom shows the doses taken on the days it appeared, with options to edit or delete the entry.Weekly check-ins. Once a week, Today asks whether anything came up. The check-in can also appear right after a scheduled dose is logged, and users can turn it off or back on from Symptoms.Units to draw. Stack and protocol details now show how many units to draw.End-of-protocol countdown. During a protocol’s final week, Stack, Today, and protocol details display the number of days left.

Since launching in May 2026, Peptide Tracker has surpassed 50,000 downloads and maintains a 4.9-star average rating on the App Store.

Version 2.25.0 is available now on the App Store and Google Play.

About Peptide Tracker: Peptide Tracker is a free iOS and Android app that helps people log doses, manage protocols, set reminders, and track their progress over time. Founded in 2026 by Kevin Miller and JP Sio, Peptide Tracker is built by Flat Six Labs. Peptide Tracker is a tracking tool and does not provide medical advice.

Media Contact
Kevin Miller
kevin@peptidetracker.ai

View original content:https://www.prnewswire.com/news-releases/peptide-tracker-adds-symptom-tracking-and-weekly-check-ins-in-v2-25-0–302910652.html

SOURCE Peptide Tracker